Revenue Summary of MedinCell S.A.

MedinCell S.A.'s latest annual revenue in 2024 was 9.16 Million EUR , down -7.88% from previous year.
MedinCell S.A.'s latest quarterly revenue in 2024 FY was 9.03 Million EUR , down -9.17% from previous quarter.
MedinCell S.A. reported a annual revenue of 9.94 Million EUR in annual revenue 2023, up 143.13% from previous year.
MedinCell S.A. reported a annual revenue of 4.09 Million EUR in annual revenue 2022, down -50.04% from previous year.
MedinCell S.A. reported a quarterly revenue of 4.09 Million EUR for 2024 Q1, up 5.9% from previous quarter.
MedinCell S.A. reported a quarterly revenue of 1.88 Million EUR for 2024 Q3, down -73.05% from previous quarter.

Annual Revenue Chart of MedinCell S.A. (2024 - 2016)

Historical Annual Revenue of MedinCell S.A. (2024 - 2016)

Year	Revenue	Revenue Growth
2024	9.16 Million EUR	-7.88%
2023	9.94 Million EUR	143.13%
2022	4.09 Million EUR	-50.04%
2021	8.18 Million EUR	187.03%
2020	2.85 Million EUR	97.64%
2019	1.44 Million EUR	-77.59%
2018	6.43 Million EUR	-24.55%
2017	8.53 Million EUR	3.66%
2016	8.23 Million EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q2	6.98 Million EUR	70.78%
2024 Q1	4.09 Million EUR	5.9%
2024 Q3	1.88 Million EUR	-73.05%
2024 FY	9.03 Million EUR	-9.17%
2024 Q4	1.88 Million EUR	0.0%
2023 Q2	6.02 Million EUR	56.36%
2023 Q4	3.86 Million EUR	29.9%
2023 Q1	3.85 Million EUR	54.99%
2023 FY	9.94 Million EUR	143.13%
2023 Q3	2.97 Million EUR	-50.67%
2022 Q1	2.03 Million EUR	-70.7%
2022 FY	4.09 Million EUR	-50.04%
2022 Q4	2.48 Million EUR	16.79%
2022 Q3	2.12 Million EUR	32.84%
2022 Q2	1.6 Million EUR	-21.4%
2021 Q1	1.57 Million EUR	75.75%
2021 Q4	6.96 Million EUR	176.19%
2021 Q3	2.52 Million EUR	105.55%
2021 Q2	1.22 Million EUR	-22.06%
2021 FY	8.18 Million EUR	187.03%
2020 FY	2.85 Million EUR	97.64%
2020 Q2	1.95 Million EUR	0.13%
2020 Q3	1.04 Million EUR	-46.58%
2020 Q4	895 Thousand EUR	-14.4%
2020 Q1	1.95 Million EUR	74.04%
2019 Q3	1.12 Million EUR	24.71%
2019 FY	1.44 Million EUR	-77.59%
2019 Q2	900.5 Thousand EUR	0.0%
2019 Q1	900.5 Thousand EUR	-67.8%
2019 Q4	1.12 Million EUR	0.0%
2018 Q3	2.79 Million EUR	106.54%
2018 Q4	2.79 Million EUR	0.0%
2018 FY	6.43 Million EUR	-24.55%
2018 Q1	1.35 Million EUR	0.0%
2018 Q2	1.35 Million EUR	0.0%
2017 FY	8.53 Million EUR	3.66%
2016 FY	8.23 Million EUR	0.0%

Peer Revenue Comparison of MedinCell S.A.

Name	Revenue	Revenue Difference
Eiger BioPharmaceuticals, Inc.	15.77 Million USD	41.926%
Nanobac Pharmaceuticals, Incorporated	17.62 Thousand USD	-51883.429%
SQZ Biotechnologies Company	21.47 Million USD	57.352%
Evofem Biosciences, Inc.	18.21 Million USD	49.72%
Santhera Pharmaceuticals Holding AG	122.95 Million USD	92.55%
Mesoblast Limited	5.9 Million USD	-55.202%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	668.8 Million USD	98.63%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	-2133.248%
Marizyme, Inc.	645.81 Thousand USD	-1318.374%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	76.76 Thousand USD	-11833.143%
Intellipharmaceutics International Inc.	65.72 Thousand USD	-13836.222%
AXIM Biotechnologies, Inc.	39.51 Thousand USD	-23079.311%
MultiCell Technologies, Inc.	49.32 USD	-18572487.186%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	49.72 Million USD	81.577%
EV Biologics, Inc.	48.9 Thousand USD	-18632.106%
Q BioMed Inc.	284.35 Thousand USD	-3121.359%
Emmaus Life Sciences, Inc.	29.59 Million USD	69.051%
Neon Bloom, Inc.	- USD	-Infinity%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	245.31 Million USD	96.266%
Oncotelic Therapeutics, Inc.	70 Thousand USD	-12985.714%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	98.99 Thousand USD	-9153.086%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	75.72 Thousand USD	-11996.561%
IMV Inc.	- USD	-Infinity%
Acro Biomedical Co., Ltd.	658.5 Thousand USD	-1291.04%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	14.69 Billion USD	99.938%
Halberd Corporation	999.00 USD	-916816.917%
Enzolytics Inc.	52.79 Thousand USD	-17249.799%
Resverlogix Corp.	- USD	-Infinity%
Affymax, Inc.	1.36 Million USD	-569.102%
SYBLEU INC	11.69 Thousand USD	-78217.373%
Nuo Therapeutics, Inc.	608.52 Thousand USD	-1405.279%
argenx SE	1.22 Billion USD	99.253%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	1.93 Million USD	-374.12%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	617.38 Thousand USD	-1383.68%
Zenith Capital Corp.	- USD	-Infinity%
Genscript Biotech Corporation	839.52 Million USD	98.909%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	- USD	-Infinity%
WPD Pharmaceuticals Inc.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	145.09 Million USD	93.687%
Provectus Biopharmaceuticals, Inc.	557.71 Thousand USD	-1542.431%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	997.72 Thousand USD	-818.088%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	48.35 Million USD	81.056%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
BioStem Technologies, Inc.	16.68 Million USD	45.102%
ONE Bio Corp.	52.29 Million USD	82.484%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	236.56 Thousand USD	-3772.168%
Regen BioPharma, Inc.	236.56 Thousand USD	-3772.168%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	140.24 Thousand USD	-6431.567%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	473.73 Thousand USD	-1833.591%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	7.78 Million USD	-17.602%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	13 Thousand USD	-70361.538%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	39.53 Thousand USD	-23069.93%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	3.33 Million USD	-175.075%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	6.66 Million USD	-37.434%
IntelGenx Technologies Corp.	1.03 Million USD	-781.617%
Gelesis Holdings, Inc.	25.76 Million USD	64.451%
CSL Limited	14.8 Billion USD	99.938%
Cellectis S.A.	755 Thousand USD	-1113.245%

Global Stocks Search

MedinCell S.A. (MDCLF)

Revenue Summary of MedinCell S.A.

Annual Revenue Chart of MedinCell S.A. (2024 - 2016)

Historical Annual Revenue of MedinCell S.A. (2024 - 2016)

Peer Revenue Comparison of MedinCell S.A.